Discover Thomson Reuters
Higher sales of cholesterol and arthritis drugs pushed Pfizer's rising profit past analysts' estimates. But as Fred Katayama reports, the drugmaker cut its full-year revenue forecast.
00:59
02:10
01:45
07:21
01:58
01:29
02:07
01:53
02:09
01:49
01:05
01:09
00:37
01:10
01:46
01:13
01:37
01:36
01:42